Comparison between Crop Life Science IPO and Mono Pharmacare IPO.
IPO Details
Crop Life Science IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Mono Pharmacare IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of Crop Life Science IPO is up to ₹25.38 Cr whereas the issue size of the Mono Pharmacare IPO is up to ₹14.07 Cr. The final issue price of Crop Life Science IPO is ₹52.00 per share and of Mono Pharmacare IPO is ₹28.00 per share.
Crop Life Science IPO opens on Aug 18, 2023, while Mono Pharmacare IPO opens on Aug 28, 2023. The closing date of Crop Life Science IPO and Mono Pharmacare IPO is Aug 22, 2023, and Aug 30, 2023, respectively.
In the Crop Life Science IPO Retail Individual Investors (RII) are offered 24,40,000 shares while in Mono Pharmacare IPO retail investors are offered 24,40,000 shares. Qualified Institutional Buyers (QIB) are offered in Crop Life Science IPO and 5,00,000 shares in Mono Pharmacare IPO.